Carrie L. Bourdow
About Carrie L. Bourdow
Carrie L. Bourdow is the President, CEO, and Chair of the Board at Trevena, Inc., with extensive experience in pharmaceutical marketing and operations.
Professional Background of Carrie L. Bourdow
Carrie L. Bourdow has a rich and diverse professional background, particularly in the pharmaceutical industry. She has held various senior positions at Trevena since joining in May 2015, including Chief Commercial Officer, Executive Vice President, and Chief Operating Officer. Before her current role, she was Vice President of Marketing at Cubist Pharmaceuticals, Inc., where she led the launch strategy, marketing, reimbursement, and operations for five acute care hospital pharmaceuticals generating over $1 billion in annual revenues. Carrie also has over 20 years of experience at Merck & Co., Inc., where she held multiple positions of increasing responsibility across various therapeutic areas.
Carrie L. Bourdow's Current Role at Trevena
Carrie L. Bourdow serves as the President and Chief Executive Officer of Trevena, Inc. She was appointed to this role in October 2018 and also became a member of the Trevena Board of Directors at that time. As of November 2023, she has taken on the additional responsibility of Chair of the Board. Carrie has been instrumental in leading the company through various phases of growth and development since her appointment.
Carrie L. Bourdow's Leadership Positions
Carrie L. Bourdow has served in multiple leadership roles throughout her career. At Trevena, she progressed from Chief Commercial Officer to Executive Vice President and Chief Operating Officer by January 2018, before being named President and CEO in October 2018. She also held the position of Vice President of Marketing at Cubist Pharmaceuticals until its acquisition by Merck & Co., Inc., where she was responsible for significant revenue-driving strategies. Carrie also has a long tenure at Merck & Co., Inc., with more than 20 years in various increasing responsibilities across numerous therapeutic areas.
Carrie L. Bourdow's Board Memberships
In addition to her executive roles, Carrie L. Bourdow has been an active board member in the biopharmaceutical industry. She was a member of the board of directors for Sesen Bio from February 2020 until March 2023. She also served on the board of directors for Nabriva Therapeutics plc. from June 2017 until July 2023. These positions underline her broad experience and influence in the industry, contributing to the strategic and operational guidance at top-tier pharmaceutical companies.